Innovating Treatments for Unmet Medical Needs
By combining scientific innovation with proven technologies, we aim to develop individualized therapies that provide new hope for those who have been left behind by existing treatments.
Revolutionizing Mental Health Care for Those Who Need It Most
Depression affects over 280 million people worldwide, yet for many, traditional treatments fail to provide relief. In the US alone, close to 3M patients with major depressive disorder experience treatment-resistant depression (TRD) – a debilitating condition where standard medications and therapies do not work.
The standard of care for TRD is electroconvulsive therapy (ECT), which has notable side effects such as memory loss. Individuals with TRD often struggle for years, cycling through treatments with limited options, which significantly impacts their quality of life.
Tailoring therapies to the unique needs of each patient
Advancing next-generation solutions for complex mental health challenges